Neumora Therapeutics, Inc.
corporate_fare Company Profile
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for NMRA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Neumora Reports Positive Phase 1b Results for NMRA-511 in Alzheimer's Agitation; Advances Pipeline
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$236.93M
Diluted EPS
-$1.45
Op. Cash Flow
-$206.44M
Operating Income
-$241.16M
Cash & Equivalents
$182.53M
Total Debt
$54.53M
Debt / Equity
0.52×
Shares Outstanding
174.26M sh
Source: 10-K · filed 2026-03-30 · accession 0001193125-26-130388
show_chartPrice Chart
Loading chart...
feed NMRA - Filings & News (Page 2)
NMRA
Jan 05, 2026, 6:45 AM EST
Price at Filing:
$1.86
Real-time Price:
$0.320
Change:
-$1.54 (-83%)
Market Cap:
$63.005M